日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of a First-in-Class Click Chemistry-Based Cancer Therapeutic, from Preclinical Evaluation to a First-in-Human Dose Escalation Clinical Trial

开发一种首创的基于点击化学的癌症治疗药物,从临床前评估到首次人体剂量递增临床试验

Sangeetha Srinivasan ,Nathan A Yee ,Maša Alečković ,Michael Zakharian ,Amir Mahmoodi ,Stefanie Wagner ,Tri-Hung Nguyen ,Sant P Chawla ,Alexander D Guminski ,José M Mejía Oneto

Gene and Cell Therapy for Sarcomas: A Review

肉瘤的基因和细胞疗法:综述

Chawla, Sant P; Pang, Skyler S; Jain, Darshit; Jeffrey, Samantha; Chawla, Neal S; Song, Paul Y; Hall, Frederick L; Gordon, Erlinda M

Phase Ia/b Multicenter Study of BPM31510IV Targeting Mitochondrial Metabolism/Warburg Effect as Monotherapy and Combination Chemotherapy in Solid Tumor Patients

BPM31510IV靶向线粒体代谢/瓦博格效应的Ia/b期多中心研究:单药治疗及联合化疗治疗实体瘤患者

Subbiah, Vivek; Yu, Peter P; Sarangarajan, Rangaprasad; Kiebish, Michael A; Rodrigues, Leonardo O; Miller, Gregory M; Akmaev, Viatcheslav R; Luan, Shen; McCook, John P; Tanna, Nikunj; Reilly, Tracey; Chen, Emily; Bussberg, Valerie; Ravipaty, Shobha; Vishnudas, Vivek K; Gesta, Stephane; Lucius, David; Bruce, Can; Hazarika, Suwagmani; Lyng, Arianne; Klotz, Allison; Tolstikov, Vladimir; Stevens, Janice; Chua, Victoria S; Granger, Elder; Tekumalla, Poornima K; Benaim, Ely; Modur, Vijay; Rudoltz, Marc S; Song, Paul Y; Tagawa, Scott T; Hendifer, Andrew; Chawla, Sant P; Shah, Manish A; Hong, David S; Zinner, Ralph; Narain, Niven R; Kundranda, Madappa N

SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcoma

SaLudo:一项随机 IIb/III 期研究,评估 lurbinectedin 联合多柔比星作为平滑肌肉瘤一线治疗方案的疗效

Cote, Gregory M; Chawla, Sant P; Demetri, George; Kasper, Bernd; Jones, Robin L; Broto, Javier Martin; Wooley, Joseph; Weiss, Mia C; Tafuto, Salvatore; Badalamenti, Giuseppe; Carrasco, Irene; Peinado, Paloma; Blay, Jean-Yves; Boggio, Gaston; Fernandez, Cristian; Nieto, Antonio; Kahatt, Carmen; Alfaro, Vicente; Le Cesne, Axel

A phase I, open-label, multicentre, first-in-human study to evaluate safety, pharmacokinetics and efficacy of AMG 404, a PD-1 inhibitor, in patients with advanced solid tumours

一项 I 期、开放标签、多中心、首次人体试验,旨在评估 PD-1 抑制剂 AMG 404 在晚期实体瘤患者中的安全性、药代动力学和疗效。

Price, Timothy; Lugowska, Iwona; Chawla, Sant P; Falchook, Gerald; Subbiah, Vivek; Monzon, Jose G; Arkenau, Hendrik-Tobias; Hui, Mun; Kuboki, Yasutoshi; Dziadziuszko, Rafal; Shibaki, Ryota; Hong, Min Hee; Tan, Daniel; Rocha Lima, Caio Max; Wang, Kejia; Hindoyan, Antreas; Shi, Weibing; Wong, Hansen; Kistler, Mira; Prenen, Hans

Editorial: Celebrating the 200th mendel's anniversary: gene-targeted diagnostics and therapies for cancer

社论:庆祝孟德尔诞辰200周年:癌症的基因靶向诊断和治疗

Federman, Noah; Gordon, Erlinda M; Chawla, Sant P; Hall, Frederick L

Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma

舒尼替尼或西地尼布治疗肺泡软组织肉瘤的随机II期试验

Nguyen, James; Takebe, Naoko; Kummar, Shivaani; Razak, Albiruni; Chawla, Sant P; George, Suzanne; Patel, Shreyaskumar R; Keohan, Mary Louise; Movva, Sujana; O'Sullivan Coyne, Geraldine; Do, Khanh; Juwara, Lamin; Augustine, Brooke; Steinberg, Seth M; Kuhlmann, Laura; Ivy, S Percy; Doroshow, James H; Chen, Alice P

Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma

INBRX-109(一种第三代重组人源化死亡受体5激动剂抗体)在软骨肉瘤中的临床前表征和I期试验结果

Vivek Subbiah ,Sant P Chawla ,Anthony P Conley ,Breelyn A Wilky ,Anthony Tolcher ,Nehal J Lakhani ,David Berz ,Vasily Andrianov ,William Crago ,Monica Holcomb ,Abrahim Hussain ,Carson Veldstra ,James Kalabus ,Brianne O'Neill ,Lane Senne ,Emily Rowell ,Analeah B Heidt ,Katelyn M Willis ,Brendan P Eckelman

SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue Sarcoma

SAINT:一项使用安全剂量的伊匹木单抗、纳武利尤单抗和曲贝替定作为晚期软组织肉瘤一线治疗的 I 期/扩展 II 期研究

Gordon, Erlinda Maria; Chawla, Sant P; Tellez, Walter Andree; Younesi, Elan; Thomas, Sonu; Chua-Alcala, Victoria S; Chomoyan, Hripsime; Valencia, Chrysler; Brigham, Don Arlen; Moradkhani, Ania; Quon, Doris; Srikureja, Amornchit; Wong, Steven G; Tseng, William; Federman, Noah

Activity of TNT: a phase 2 study using talimogene laherparepvec, nivolumab and trabectedin for previously treated patients with advanced sarcomas (NCT# 03886311)

TNT 的活性:一项使用 talimogene laherparepvec、nivolumab 和 trabectedin 治疗既往接受过治疗的晚期肉瘤患者的 2 期研究 (NCT# 03886311)

Chawla, Sant P; Tellez, Walter Andree; Chomoyan, Hripsime; Valencia, Chrysler; Ahari, Amir; Omelchenko, Nadezhda; Makrievski, Stefan; Brigham, Don A; Chua-Alcala, Victoria; Quon, Doris; Moradkhani, Ania; Gordon, Erlinda M